Status: Not yet recruiting
Study of EPN-701 for the Treatment of Calciphylaxis
Calciphylaxis is a rare but serious condition that leads to painful skin lesions. At present, there is no approved treatment for calciphylaxis. This research study is planned to examine the potential benefits of a new treatment (EPN-701) in patients with calciphylaxis. The present early clinical study will also evaluate the pharmacology of EPN-701 and whether it can be safely used in patients with calciphylaxis. Findings will inform the planning of a future definitive study to establish EPN-701 as an approved treatment for calciphylaxis.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Sagar U. Nigwekar, MD, MMScUpdated: Jun 29, 2026Locations: 1
Eligibility criteria
Participant must provide written or electronic consent after the nature of the s... [+7]
In the opinion of the Investigator, presence of any clinically significant disea... [+12]